Delivery Order SPE2DB22D9316-SPE2DB24FYP39

Award Date 6/10/24
Potential Completion Date 7/2/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,006.95 contract is for the supply of LENVIMA 20 MG DAILY DOSE 60S, a pharmaceutical product, with a period of performance through January 3, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the delivery of Lenvima 10 mg daily dose 30s, a specialized prescription medication. The contract has an ultimate completion date of December 10, 2024 and was awarded on November 18, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,662.16 award is for the procurement of LENVIMA 14 MG DAILY DOSE 60S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a prescription medication, with a period of performance through August 5, 2024. This delivery order contract was issued under DMS Pharmaceutical Group's existing, single-award indefinite delivery contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,662.16, is for the delivery of Lenvima 10 mg daily dose 30s, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,261.09, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price contract is for the supply of Lenvima 24 mg daily dose prescription medication. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the delivery of LENVIMA 20 MG DAILY DOSE 60S, a specialized pharmaceutical product. The contract has a completion date of February 14, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract, valued at $10,662.16, is for the delivery of LENVIMA 24 MG DAILY DOSE 90S, a pharmaceutical product. This award does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product LENVIMA 4 MG CAPSULE 30S, with a ceiling value of $99,062.55 and a period of performance through July 5, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, under the SPE2DB program, valued at...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP39
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of LENVIMA 20 MG DAILY DOSE 60S, with a ceiling value of $11,006.95 and a period of performance through July 2, 2024.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The award described is one such delivery order issued under this IDC. DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 9/9/24, 11:12 AM